1. Introduction {#sec1-jcm-09-01357}
===============

Heat stroke is a hazardous and potentially life-threatening form of heat-related illness characterized by the presence of an increasing core body temperature higher than 40.5 °C \[[@B1-jcm-09-01357],[@B2-jcm-09-01357],[@B3-jcm-09-01357]\]. It is accompanied by neurological dysfunction such as confusion, seizure, and an alteration of consciousness \[[@B4-jcm-09-01357]\]. Heat stroke is mainly classified into two subcategories, exertional heat stroke and non-exertional heat stroke, also known as "classic" heat stroke \[[@B5-jcm-09-01357]\]. Exertional heat stroke commonly occurs among young healthy persons who are vigorously active in environments with high ambient temperatures and humidity levels \[[@B6-jcm-09-01357],[@B7-jcm-09-01357]\]. By contrast, classic heat stroke is frequently found among older patients with underlying medical conditions that impair their ability to dissipate heat and intervene in their access to hydration \[[@B8-jcm-09-01357],[@B9-jcm-09-01357],[@B10-jcm-09-01357]\].

Under normal conditions, when patients are exposed to a hot environment, the cardiovascular system enhances cardiac output, aiming to increase blood flow to the skin for cooling \[[@B11-jcm-09-01357]\]. This defense mechanism increases the oxygen consumption of the heart and might potentially precipitate a myocardial infarction. Therefore, the association between high temperature and ischemic heart disease has been investigated in recent past years. A previous study demonstrated that higher environmental temperatures are associated with an increase in the risk of myocardial infarction \[[@B12-jcm-09-01357]\]. However, this effect is only influential during the first six hours after exposure \[[@B12-jcm-09-01357]\]. Furthermore, the study previously showed that heat stroke was associated with a higher risk of subsequent acute myocardial infarction and higher mortality \[[@B13-jcm-09-01357]\].

Consequently, identifying risk factors of acute myocardial infarction among heat stroke patients who might be a potentially high risk for the condition, aiming to detect it early and begin treatment, might reduce serious complications and mortality. However, knowledge of risk factors and the impact of acute myocardial infarction among hospitalized heat stroke patients are limited and remain unclear.

Therefore, we conducted this study with the aim of assessing the risk factors and impact of acute myocardial infarction on in-hospital treatments, complications, outcomes, and resource use among patients hospitalized for heat stroke in the United States.

2. Materials and Methods {#sec2-jcm-09-01357}
========================

2.1. Data Source {#sec2dot1-jcm-09-01357}
----------------

This cohort study was conducted using the 2003--2014 National Inpatient Sample (NIS) database. The NIS is the largest all-payer inpatient database in the United States. Discharge dataset from a 20% stratified sample of hospitals in United States with the patient encounter-level information, which includes principal and secondary diagnosis codes as well as procedure codes, are recorded in the NIS. Sample weight is used to generate national estimates for hospitalization nationwide. The approval from the institutional review board was exempted as the information was obtained from a de-identified public database. This study adhered to the policy for protection of human subjects according to Declaration of Helsinki.

2.2. Study Population {#sec2dot2-jcm-09-01357}
---------------------

Our study included all patients who were admitted in hospitals from 2003 to 2014 with a principal diagnosis of heat stroke, based on International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) diagnosis code of 992.0. Heat stroke patients who developed acute myocardial infarction were identified using ICD-9 diagnosis of 410.xx.

2.3. Data Collection {#sec2dot3-jcm-09-01357}
--------------------

Patient characteristics, treatments, complication, and outcomes during hospitalization were identified using ICD-9 codes ([Table S1](#app1-jcm-09-01357){ref-type="app"}). Patient characteristics included age, sex, race, smoking, alcohol drinking, obesity, diabetes mellitus, hypertension, hypothyroidism, chronic kidney disease, coronary artery disease, congestive heart failure, and atrial flutter/fibrillation. Treatments included invasive mechanical ventilation, blood component transfusion, and renal replacement therapy. Complications and outcomes included electrolyte derangements (hyponatremia, hypernatremia, hypokalemia, hyperkalemia, hypocalcemia, hypercalcemia, metabolic acidosis, and metabolic alkalosis), rhabdomyolysis, sepsis, gastrointestinal bleeding, ventricular arrhythmia or cardiac arrest, and end-organ failure (renal failure, respiratory failure, liver failure, neurological failure, and hematological failure), and in-hospital mortality. Resource utilization included length of hospital stay and hospitalization cost.

2.4. Statistical Analysis {#sec2dot4-jcm-09-01357}
-------------------------

The total number of heat stroke patients was estimated using discharge-level weights provided by the Healthcare Cost and Utilization Project (HCUP). Continuous variables were reported as mean ± standard deviation and were compared using student's t-test. Categorical variables were presented as counts with percentage and were compared using Chi-squared test. Multivariable logistic regression was performed to assess if there were clinical characteristics independently associated with acute myocardial infarction. The association of acute myocardial infarction with in-hospital treatments, complications, and outcomes was assessed using logistic regression analysis, and with length of hospital stay and hospitalization cost using linear regression analysis, with pre-specified adjustment for age, sex, smoking, alcohol drinking, and comorbidities. All analyses were two-tailed. Statistical significance was achieved when *p*-value \< 0.05. SPSS statistical software (version 22.0, IBM Corporation, Armonk, NY, USA) was used for all analyses.

3. Results {#sec3-jcm-09-01357}
==========

3.1. Incidence of and Risk Factors for Acute Myocardial Infarction in Hospitalized Heat Stroke Patients {#sec3dot1-jcm-09-01357}
-------------------------------------------------------------------------------------------------------

A total of 3372 hospitalized heat stroke patients were included in analysis. Of these, 225 (7%) had acute myocardial infarction in hospital. [Table 1](#jcm-09-01357-t001){ref-type="table"} compared clinical characteristics, in-hospital treatments, complications, outcomes, and resource utilization between heat stroke patients with and without acute myocardial infarction. Patients with acute myocardial infarction were older, were more likely to be female, but less likely to be smokers, and had more comorbidities, including obesity, diabetes mellitus, hypertension, chronic kidney disease, coronary artery disease, and congestive heart failure, compared with patients without acute myocardial infarction.

In multivariable analysis, obesity (OR 1.78; *p* = 0.01) and history of chronic kidney disease (OR 1.61; *p* = 0.04) were independently associated with increased risk of acute myocardial infarction, whereas age \< 20 (OR 0.27; *p* = 0.01), male sex (OR 0.58; *p* \< 0.001), and history of hypothyroidism (OR 0.33; *p* = 0.005) were associated with decreased risk of acute myocardial infarction ([Table 2](#jcm-09-01357-t002){ref-type="table"}).

3.2. The Association of Acute Myocardial Infarction with In-Hospital Treatments, Complications, and Outcomes {#sec3dot2-jcm-09-01357}
------------------------------------------------------------------------------------------------------------

In terms of in-hospital treatments, acute myocardial infarction was significantly associated with higher requirement of invasive mechanical ventilation (OR 4.53; *p* \< 0.001), blood component transfusion (OR 4.57; *p* \< 0.001), and renal replacement therapy (OR 2.32; *p* = 0.02). Eighteen (8%) and one (0.4%) of the patients with acute myocardial infarction underwent coronary angiogram ± percutaneous coronary intervention and thrombolytic therapy, whereas none of the patients without acute myocardial infarction received these treatments. In term of in-hospital complications and outcomes, acute myocardial infarction was significantly associated with rhabdomyolysis (OR 1.87; *p* \< 0.001), metabolic acidosis (OR 2.22; *p* \< 0.001), sepsis (OR 3.31; *p* \< 0.001), gastrointestinal bleeding (OR 10.95; *p* \< 0.001), ventricular arrhythmia/cardiac arrest (OR 3.07; *p* \< 0.001), renal failure (OR 1.85; *p* \< 0.001), respiratory failure (OR 4.64; *p* \< 0.001), circulatory failure (OR 1.79; *p* = 0.002), liver failure (OR 5.48; *p* \< 0.001), neurological failure (OR 1.96; *p* \< 0.001), and hematological failure (OR 5.21; *p* \< 0.001). In addition, acute myocardial infarction was significantly associated with increased in-hospital mortality (OR 5.21; *p* \< 0.001) ([Table 3](#jcm-09-01357-t003){ref-type="table"}).

In-hospital mortality was 0.3%, 1.0%, 5.2%, and 15.6% for patients with 0, 1, 2, and ≥3 in-hospital complications, respectively (*p* \< 0.001). There was no interaction between acute myocardial infarction and these in-hospital complications on in-hospital mortality (all *p*-interaction \> 0.05).

3.3. Impact of Acute Myocardial Infarction on Resource Utilization {#sec3dot3-jcm-09-01357}
------------------------------------------------------------------

Acute myocardial infarction was associated with increased mean length of stay by 3.9 (95% CI 3.0--4.8) days and increased mean hospitalization cost by \$41,321 (95% CI 31,465--51,177) ([Table 3](#jcm-09-01357-t003){ref-type="table"}).

4. Discussion {#sec4-jcm-09-01357}
=============

This large cohort study of 3372 patients found that acute myocardial infarction occurred in 7% of patients hospitalized for heat stroke. We identified that obesity and chronic kidney disease were independently associated with increased risk of in-hospital acute myocardial infarction, while age \<20 years, male sex, and hypothyroidism were independently associated with decreased risk. Heat stroke patients with in-hospital acute myocardial infarction had higher in-hospital mortality, and greater incidence of several serious complications, and required more resource utilization, compared to patients without acute myocardial infarction.

The impact of acute myocardial infarction includes an increase in in-hospital mortality, incidence of several serious complications, and resource use \[[@B14-jcm-09-01357]\]. Heat stroke patients with acute myocardial infarction were five times more likely to die in hospital than patients without it. In addition to its mortality rate, acute myocardial infarction is strongly associated with gastrointestinal bleeding among heat stroke patients. The rates of mortality and gastrointestinal bleeding among acute myocardial infarction in our study were higher than other cohorts of patients with acute myocardial infarction, suggesting the high impact of acute myocardial infarction on patients hospitalized for heat stroke \[[@B15-jcm-09-01357],[@B16-jcm-09-01357],[@B17-jcm-09-01357],[@B18-jcm-09-01357]\]. Our study also suggested that patients with acute myocardial infarction hospitalized for heat stroke were more likely to develop concomitant multiorgan failure and other complications, including rhabdomyolysis, metabolic acidosis, sepsis, gastrointestinal bleeding, ventricular arrhythmia, or cardiac arrest. In addition, the economic burden is one of the issues that should also be noted. The length of hospital stay and hospitalization costs were higher when an acute myocardial infarction occurred while hospitalized for heat stroke. The hospitalization costs of patients complicated with acute myocardial infarction were more than two times higher than those without it. This could potentially be due to higher concomitant multiorgan failure and other complications requiring more invasive mechanical ventilator and renal replacement therapy among hospitalized patients for heat stroke with acute myocardial infarction (AMI).

The hemodynamic response to a hot environment increases both the function of the heart and oxygen consumption, leading to a risk of myocardial infarction. In our study, we demonstrated that obesity and chronic kidney disease are important risk factors for in-hospital acute myocardial infarction among patients hospitalized for heat stroke, consistent with findings from Wang et al. \[[@B13-jcm-09-01357]\]. This is supported by the fact that chronic kidney disease and obesity are risk factors of cardiovascular diseases \[[@B19-jcm-09-01357],[@B20-jcm-09-01357]\]. While smoking, diabetes mellitus, and hypertension are well known major risk factors of myocardial infarction \[[@B21-jcm-09-01357],[@B22-jcm-09-01357]\], they were not demonstrated at a statistically significant level in multivariable analysis in our study. Although the underlying explanation remains unclear, it is possible that myocardial infarction among patients with heat stroke is type 2 myocardial infarction that occurs secondary to an acute imbalance in myocardial oxygen supply and demand without atherothrombosis \[[@B23-jcm-09-01357],[@B24-jcm-09-01357]\]. Catecholamines induced type 2 myocardial injury/infarction among patients with heat stroke have been reported \[[@B23-jcm-09-01357],[@B24-jcm-09-01357],[@B25-jcm-09-01357]\], and it is possible that the risk for type 2 myocardial infarction among patients with heat stroke might be decreased among males and patients with hypothyroid due to the lesser degree of catecholamine release \[[@B26-jcm-09-01357],[@B27-jcm-09-01357]\]. Previous studies have also shown that patients with type 2 myocardial infarction are older and more often females \[[@B21-jcm-09-01357],[@B28-jcm-09-01357]\], which are consistent with the findings of decreased risk of heat stroke associated myocardial infarction among young male patients in our study.

Several limitations should be pinpointed in our study. First, the NIS is a cohort of hospitalized patients. We expect that the need for hospitalization generally indicates more severe cases of heat stroke or heat stroke in high-risk populations. Therefore, we should be cautious of selection bias. The result might not be generalizable to all heat stroke patients. Second, given the lack of timing of acute myocardial infarction and other complications during hospitalization, we cannot establish their temporal relationship. Therefore, the association between acute myocardial infarction and other in-hospital complications might be bi-directional. Third, the diagnosis of acute myocardial infarction in this study was not based on symptoms, electrocardiogram, cardiac injury biomarkers, or coronary angiogram, but we used the diagnosis code due to the nature of the NIS database. Therefore, the diagnosis of acute myocardial infarction can be heterogeneous and potentially inaccurate. The timing of symptom onset and treatment for revascularization was also lacking. Additionally, the diagnosis code did not provide a sub-classification of heat stroke to indicate whether it was exertional or non-exertional heat stroke, which have different characteristics and severity. Fourth, given the administrative nature of the dataset, the data on medication treatment were limited in this study. Thus, future studies are needed to assess whether the aggressive treatment with the thrombolytic, anticoagulant, and antiplatelet agents accompanied by hematological failure in heat stroke patients might explain this bleeding-related complication. Finally, we could only demonstrate the short-term complications and outcomes during their hospitalizations. Long-term outcomes of acute myocardial infarction after hospital discharge among heat stroke patients were not reported. Nevertheless, our study's strength is worth mentioning. Our study is the largest observational study to date, including 3372 heatstroke patients of various ages, ethnicities, and underlying diseases.

5. Conclusions {#sec5-jcm-09-01357}
==============

In summary, acute myocardial infarction occurred in 7% of patients hospitalized for heat stroke, but its impact should be recognized. Acute myocardial infarction was associated with higher mortality, and occurrence of several serious complications, particularly gastrointestinal bleeding, and organ failures. Obesity and chronic kidney disease were associated with higher risk of acute myocardial infarction, while teenage youth, male sex, and hypothyroidism were associated with lower risk.

The following are available online at <https://www.mdpi.com/2077-0383/9/5/1357/s1>, Table S1: ICD-9 code for patient characteristics, treatments, and outcomes.
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###### 

Clinical characteristics, in-hospital treatments, complications, outcomes, and resource utilization in heat stroke patients.

                                                       Total             Acute Myocardial Infarction   No Acute Myocardial Infarction   *p*-Value
  ---------------------------------------------------- ----------------- ----------------------------- -------------------------------- -----------
  Clinical characteristics                                                                                                              
  N (%)                                                3372              225 (6.7)                     3147 (93.3)                      
  Age (years)                                          55 ± 22           62 ± 20                       54 ± 22                          \<0.001
  \<20                                                 218 (6.5)         4 (1.8)                       214 (6.8)                        \<0.001
  20--39                                               654 (19.4)        27 (12.0)                     627 (19.9)                       
  40--59                                               1034 (30.7)       69 (30.7)                     965 (30.7)                       
  60--79                                               900 (26.7)        65 (28.9)                     835 (26.6)                       
  ≥80                                                  564 (16.7)        60 (26.7)                     504 (16.0)                       
  Sex                                                                                                                                   \<0.001
  Male                                                 2478 (73.5)       135 (60.0)                    2343 (74.5)                      
  Female                                               894 (26.5%)       90 (40.0)                     804 (25.5%)                      
  Race                                                                                                                                  0.67
  Caucasian                                            1883 (55.8)       118 (52.4)                    1765 (56.1)                      
  African American                                     496 (14.7)        33 (14.7)                     463 (14.7)                       
  Hispanic                                             428 (12.7)        33 (14.7)                     395 (12.6)                       
  Other                                                565 (16.8)        41 (18.2)                     524 (16.7)                       
  Smoking                                              604 (17.9)        22 (9.8)                      582 (18.5)                       0.001
  Alcohol drinking                                     270 (8.0)         13 (5.8)                      257 (8.2)                        0.20
  Obesity                                              233 (6.9)         26 (11.6)                     207 (6.6)                        0.004
  Diabetes Mellitus                                    562 (16.7)        56 (24.9)                     506 (16.1)                       0.001
  Hypertension                                         1255 (37.2)       112 (49.8)                    1143 (36.3)                      \<0.001
  Dyslipidemia                                         495 (14.7)        41 (18.2)                     454 (14.4)                       0.12
  Hypothyroidism                                       196 (5.8)         7 (3.1)                       189 (6.0)                        0.07
  Chronic kidney disease                               201 (6.0)         24 (10.7)                     177 (5.6)                        0.002
  Coronary artery disease                              389 (11.5)        37 (16.4)                     352 (11.2)                       0.02
  Congestive heart failure                             216 (6.4)         23 (10.2)                     193 (6.1)                        0.02
  Atrial flutter/fibrillation                          251 (7.4)         22 (9.8)                      229 (7.3)                        0.17
  Treatment                                                                                                                             
  Invasive mechanical ventilation                      686 (20.3)        94 (41.8)                     592 (18.8)                       \<0.001
  Blood component transfusion                          169 (5.0)         35 (15.6)                     134 (4.3)                        \<0.001
  Renal replacement therapy                            75 (2.2)          11 (4.9)                      64 (2.0)                         0.005
  Coronary angiogram ± primary coronary intervention   18 (0.5)          18 (8.0%)                     0 (0)                            N/A
  Complication and outcomes                                                                                                             
  Hyponatremia                                         293 (8.7)         14 (6.2)                      279 (8.9)                        0.17
  Hypernatremia                                        183 (5.4)         16 (7.1)                      167 (5.3)                        0.25
  Hypokalemia                                          500 (14.8)        32 (14.2)                     468 (14.9)                       0.79
  Hyperkalemia                                         134 (4.0)         10 (4.4)                      124 (3.9)                        0.71
  Hypocalcemia                                         73 (2.2)          3 (1.3)                       70 (2.2)                         0.38
  Hypercalcemia                                        37 (1.1)          1 (0.4)                       36 (1.1)                         0.33
  Rhabdomyolysis                                       1049 (31.1)       83 (36.9)                     966 (30.7)                       0.05
  Metabolic acidosis                                   472 (14.0)        50 (22.2)                     422 (13.4)                       \<0.001
  Metabolic alkalosis                                  29 (0.9)          4 (1.8)                       25 (0.8)                         0.12
  Sepsis                                               149 (4.4)         29 (12.9)                     120 (3.8)                        \<0.001
  Gastrointestinal bleeding                            54 (1.6)          16 (7.1)                      38 (1.2)                         \<0.001
  Ventricular arrhythmia/cardiac arrest                95 (2.8)          16 (7.1)                      79 (2.5)                         0.001
  Renal failure                                        1226 (36.4)       103 (45.8)                    1123 (35.7)                      0.002
  Respiratory failure                                  550 (16.3)        87 (38.7)                     463 (14.7)                       \<0.001
  Circulatory failure                                  393 (11.7)        40 (17.8)                     353 (11.2)                       0.003
  Liver failure                                        196 (5.8)         35 (15.6)                     161 (5.1)                        \<0.001
  Neurological failure                                 651 (19.3)        68 (30.2)                     583 (18.5)                       \<0.001
  Hematological failure                                449 (13.3)        60 (26.7)                     389 (12.4)                       \<0.001
  In-hospital mortality                                168 (5.0)         35 (15.6)                     133 (4.2)                        \<0.001
  Resource utilization                                                                                                                  
  Length of hospital stay (days)                       4.3 ± 7.0         8.0 ± 13.4                    4.0 ± 6.2                        \<0.001
  Hospitalization cost (\$)                            35,335 ± 72,085   72,444 ± 117,246              32,757 ± 67,112                  \<0.001

Continuous variables were reported as mean ± standard deviation; categorical variables as counts (percentages).
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###### 

Univariable and multivariable analysis assessing factors associated with acute myocardial infarction in heat stroke patients.

  Variables                     Univariable Analysis   Multivariable Analysis                       
  ----------------------------- ---------------------- ------------------------ ------------------- ---------
  Age (years)                                                                                       
  \<20                          0.26 (0.09--0.72)      0.01                     0.27 (0.10--0.76)   0.01
  20--39                        0.60 (0.38--0.95)      0.03                     0.70 (0.43--1.12)   0.13
  40--59                        1 (reference)                                   1 (reference)       
  60--79                        1.09 (0.77--1.55)      0.64                     0.91 (0.62--1.33)   0.62
  ≥80                           1.67 (1.16--2.39)      0.006                    1.35 (0.89--2.04)   0.16
  Male                          0.51 (0.39--0.68)      \<0.001                  0.58 (0.43--0.79)   \<0.001
  Race                                                                                              
  Caucasian                     1 (reference)                                   1 (reference)       
  African American              1.07 (0.72--1.59)      0.75                     0.98 (0.65--1.48)   0.91
  Hispanic                      1.25 (0.84--1.87)      0.28                     1.40 (0.92--2.12)   0.12
  Other                         1.17 (0.81--1.69)      0.40                     1.20 (0.82--1.73)   0.37
  Smoking                       0.48 (0.31--0.75)      0.001                    0.68 (0.41--1.10)   0.10
  Alcohol drinking              0.69 (0.39--1.23)      0.21                     0.89 (0.49--1.62)   0.70
  Obesity                       1.86 (1.20--2.86)      0.005                    1.78 (1.13--2.80)   0.01
  Diabetes Mellitus             1.73 (1.26--2.37)      0.001                    1.21 (0.85--1.72)   0.28
  Hypertension                  1.74 (1.33--2.28)      \<0.001                  1.28 (0.93--1.75)   0.13
  Dyslipidemia                  1.32 (0.93--1.88)      0.12                     1.07 (0.73--1.58)   0.73
  Hypothyroidism                0.50 (0.23--1.08)      0.08                     0.33 (0.15--0.71)   0.005
  Chronic kidney disease        2.00 (1.28--3.14)      0.002                    1.61 (1.01--2.56)   0.04
  Coronary artery disease       1.56 (1.08--2.26)      0.02                     1.22 (0.81--1.82)   0.35
  Congestive heart failure      1.74 (1.11--2.75)      0.02                     1.18 (0.71--1.95)   0.52
  Atrial flutter/fibrillation   1.38 (0.87--2.19)      0.17                     0.95 (0.57--1.57)   0.83
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###### 

The association between acute myocardial infarction and in-hospital treatments, complications, outcomes, and resource utilization in heat stroke patients.

                                          Univariable Analysis      Multivariable Analysis                                   
  --------------------------------------- ------------------------- ------------------------ ------------------------------- -----------
  Treatments                                                                                                                 
  Invasive mechanical ventilation         3.10 (2.34--4.10)         \<0.001                  4.53 (3.29--6.24)               \<0.001
  Blood component transfusion             4.14 (2.78--6.18)         \<0.001                  4.57 (2.97--7.04)               \<0.001
  Renal replacement therapy               2.48 (1.29--4.77)         0.007                    2.32 (1.13--4.77)               0.02
  Complications and outcomes                                                                                                 
  Hyponatremia                            0.68 (0.39--1.19)         0.18                     0.68 (0.39--1.20)               0.18
  Hypernatremia                           1.37 (0.80--2.33)         0.25                     1.37 (0.80--2.36)               0.26
  Hypokalemia                             0.95 (0.65--1.40)         0.79                     0.96 (0.64--1.42)               0.82
  Hyperkalemia                            1.13 (0.59--2.19)         0.71                     1.11 (0.57--2.17)               0.76
  Hypocalcemia                            0.59 (0.19--1.90)         0.38                     0.64 (0.20--2.09)               0.46
  Hypercalcemia                           0.39 (0.05--2.83)         0.39                     0.58 (0.08--4.38)               0.60
  Rhabdomyolysis                          1.32 (0.99--1.75)         0.05                     1.87 (1.37--2.53)               \<0.001
  Metabolic acidosis                      1.85 (1.33--2.57)         \<0.001                  2.22 (1.57--3.15)               \<0.001
  Metabolic alkalosis                     2.26 (0.78--6.55)         0.13                     1.97 (0.65--5.92)               0.23
  Sepsis                                  3.73 (2.43--5.74)         \<0.001                  3.31 (2.11--5.21)               \<0.001
  Gastrointestinal bleeding               6.26 (3.44--11.42)        \<0.001                  10.95 (3.37--35.50)             \<0.001
  Ventricular arrhythmia/cardiac arrest   2.97 (1.71--5.18)         \<0.001                  3.07 (1.71--5.48)               \<0.001
  Renal failure                           1.52 (1.16--2.00)         0.003                    1.85 (1.38--2.47)               \<0.001
  Respiratory failure                     3.66 (2.75--4.86)         \<0.001                  4.64 (3.39--6.35)               \<0.001
  Circulatory failure                     1.71 (1.20--2.45)         0.003                    1.79 (1.24--2.59)               0.002
  Liver failure                           3.42 (2.30--5.07)         \<0.001                  5.48 (3.50--8.59)               \<0.001
  Neurological failure                    1.91 (1.41--2.57)         \<0.001                  1.96 (1.45--2.67)               \<0.001
  Hematological failure                   2.58 (1.88--3.53)         \<0.001                  3.22 (2.28--4.55)               \<0.001
  In-hospital mortality                   4.17 (2.79--6.22)         \<0.001                  5.21 (3.37--8.06)               \<0.001
                                          Coefficient (95% CI)      *p*-value                Adjusted coefficient (95% CI)   *p*-value
  Resource utilization                                                                                                       
  Length of hospital stay (days)          3.9 (3.8--4.3)            \<0.001                  3.9 (3.0--4.8)                  \<0.001
  Hospitalization cost (\$)               39,687 (29,832--49,541)   \<0.001                  41,321 (31,465--51,177)         \<0.001

\* Adjusted for age, sex, race, smoking, alcohol drinking, obesity, diabetes mellitus, hypertension, dyslipidemia, hypothyroidism, chronic kidney disease, chronic ischemic heart disease, congestive heart failure, and atrial flutter/fibrillation.
